Bath & Body Works (NYSE:BBWI) Updates FY 2026 Earnings Guidance

Bath & Body Works (NYSE:BBWI) updated its FY 2026 earnings guidance on Wednesday. The company provided earnings per share guidance of 2.400-2.650 for the period, compared to the consensus earnings per share estimate of 2.560. The company issued revenue guidance of $7.0 billion-$7.1 billion, compared to the consensus revenue estimate of $7.0 billion. Bath & Body Works also updated its Q2 2026 guidance to 0.300-0.300 EPS.

Analysts Set New Price Targets

A number of research firms have commented on BBWI. UBS Group cut their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a report on Wednesday, May 20th. Telsey Advisory Group increased their price objective on shares of Bath & Body Works from $23.00 to $25.00 and gave the company a “market perform” rating in a report on Thursday, March 5th. Citigroup downgraded shares of Bath & Body Works from a “buy” rating to a “neutral” rating and increased their price objective for the company from $21.00 to $25.00 in a report on Tuesday, February 17th. TD Cowen dropped their price target on shares of Bath & Body Works from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Monday, May 18th. Finally, Piper Sandler initiated coverage on shares of Bath & Body Works in a research note on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Three analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company’s stock. According to MarketBeat, Bath & Body Works presently has a consensus rating of “Hold” and a consensus target price of $21.21.

Bath & Body Works Stock Performance

NYSE:BBWI opened at $17.78 on Wednesday. The stock has a market capitalization of $3.58 billion, a P/E ratio of 5.64, a PEG ratio of 1.77 and a beta of 1.43. The company has a 50 day moving average price of $18.67 and a 200 day moving average price of $20.26. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $33.96.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts forecast that Bath & Body Works will post 2.61 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 19th. Shareholders of record on Friday, June 5th will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a yield of 4.5%. Bath & Body Works’s dividend payout ratio is 25.40%.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds have recently added to or reduced their stakes in the business. Parallel Advisors LLC lifted its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after buying an additional 567 shares in the last quarter. Meeder Asset Management Inc. lifted its holdings in Bath & Body Works by 28.5% during the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company’s stock worth $58,000 after buying an additional 637 shares in the last quarter. State of Wyoming lifted its holdings in Bath & Body Works by 6.2% during the 2nd quarter. State of Wyoming now owns 11,294 shares of the company’s stock worth $338,000 after buying an additional 661 shares in the last quarter. Vident Advisory LLC lifted its holdings in Bath & Body Works by 2.8% during the 2nd quarter. Vident Advisory LLC now owns 25,229 shares of the company’s stock worth $756,000 after buying an additional 692 shares in the last quarter. Finally, Geneos Wealth Management Inc. lifted its holdings in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.